Re: [MOL] Intravenious octrietide treatment for cancer [02996] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Re: [MOL] Intravenious octrietide treatment for cancer



Lillian, thanks so much for getting back to me, my name is Kendall , I am
Matt's wife, and it is my father who has the cancer.  I spelled "octreotide"
wrong.  This is the correct spelling.  I was able to pull up some
information on it, but mostly it was using the "octreotide" in scans, and
not as a treatment.  Thanks for your prompt response and your help.  I hope
someone out there has some information.
-----Original Message-----
From: lillian jennings <firefly@islc.net>
To: mol-cancer@lists.meds.com <mol-cancer@lists.meds.com>
Date: Sunday, August 30, 1998 10:58 AM
Subject: Re: [MOL] Intravenious octrietide treatment for cancer


>Sender: owner-mol-cancer@a5.inet911.com
>Received: from a5.inet911.com (a5.inet911.com [199.242.194.16])
> by hil-img-1.compuserve.com (8.8.6/8.8.6/2.12) with ESMTP id NAA04477;
> Sun, 30 Aug 1998 13:57:13 -0400 (EDT)
>Received: (from majordom@localhost)
> by a5.inet911.com (8.9.0.Beta5/8.8.5) id OAA31647
> for mol-cancer-outgoing; Sun, 30 Aug 1998 14:26:07 -0400
>X-Authentication-Warning: a5.inet911.com: majordom set sender to
owner-mol-cancer@lists.meds.com using -f
>Received: from islc.net (root@[208.224.174.10])
> by a5.inet911.com (8.9.0.Beta5/8.8.5) with ESMTP id OAA31644
> for <mol-cancer@lists.meds.com>; Sun, 30 Aug 1998 14:26:01 -0400
>Received: from islc.net (p113.islc.net [208.224.174.113]) by islc.net
(8.8.5/8.7.3) with ESMTP id NAA04340 for <mol-cancer@lists.meds.com>; Sun,
30 Aug 1998 13:49:48 -0400 (EDT)
>Message-ID: <35E98CFB.602F1408@islc.net>
>Date: Sun, 30 Aug 1998 13:33:47 -0400
>From: lillian jennings <firefly@islc.net>
>X-Mailer: Mozilla 4.04 [en] (Win95; I)
>MIME-Version: 1.0
>To: mol-cancer@lists.meds.com
>Subject: Re: [MOL] Intravenious octrietide treatment for cancer
>References: <000701bdd432$fc455f20$6e619ad1@home>
>Content-Type: multipart/alternative;
boundary="------------BB9E8C0E5D0B21BEE916CED0"
>Sender: owner-mol-cancer@lists.meds.com
>Precedence: bulk
>Reply-To: mol-cancer@lists.meds.com
>
>Matt:  Welcome to our wonderful forum, a home away from home.  I was not
>able to find anything on octrietide treatment and hope one of our other
>members will be able to answer your question.  Your friend, Lillian
>
>Matt Leigh wrote:
>
>>  I am looking for information regarding intravenous octrietide
>> treatment for my father who has been diagnosed with neuroindrican
>> cancer of the pancreas. He is 54 years old and in very good health.
>> He exercises every day and is feeling great, but still the cancer is
>> there.  Surgery is not an option, so we have been told about this
>> octrietide.  If you have any information, please e-mail me at
>> flyfish@CompuServe.  Thank you.
>
>
>



------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------